These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
751 related articles for article (PubMed ID: 28920766)
1. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies. Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766 [TBL] [Abstract][Full Text] [Related]
2. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder in a paraneoplastic context. Hyun JW; Park NY; Kim MJ; Kim H; Kim KH; Kim SH; Kim HJ J Neurol Sci; 2023 Nov; 454():120825. PubMed ID: 37813018 [TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4. Iorio R; Rindi G; Erra C; Damato V; Ferilli M; Sabatelli M Mult Scler; 2015 May; 21(6):791-4. PubMed ID: 25716881 [TBL] [Abstract][Full Text] [Related]
6. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies. Guerra H; Pittock SJ; Moder KG; Fryer JP; Gadoth A; Flanagan EP Mayo Clin Proc; 2018 Sep; 93(9):1299-1304. PubMed ID: 29655487 [TBL] [Abstract][Full Text] [Related]
7. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M; J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675 [TBL] [Abstract][Full Text] [Related]
9. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders. Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911 [TBL] [Abstract][Full Text] [Related]
10. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study. Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457 [TBL] [Abstract][Full Text] [Related]
11. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review. Tao S; Zhang Y; Ye H; Guo D Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia. Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527 [TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation. Beauchemin P; Iorio R; Traboulsee AL; Field T; Tinker AV; Carruthers RL Mult Scler Relat Disord; 2018 Feb; 20():37-42. PubMed ID: 29291482 [TBL] [Abstract][Full Text] [Related]
14. Whole spinal transverse myelitis in neuromyelitis optica spectrum disorder. Etemadifar M; Mousavi S; Salari M; Hosseinian SA; Mansouri AR Mult Scler Relat Disord; 2024 Jul; 87():105666. PubMed ID: 38749352 [TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature. Cai G; He D; Chu L; Dai Q; Xu Z; Zhang Y Int J Neurosci; 2016; 126(7):660-8. PubMed ID: 26010208 [TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750 [TBL] [Abstract][Full Text] [Related]
19. The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis. Rocchi C; Forcadela M; Kelly P; Linaker S; Gibbons E; Bhojak M; Jacob A; Hamid S; Huda S Mult Scler; 2024 Mar; 30(3):345-356. PubMed ID: 38258822 [TBL] [Abstract][Full Text] [Related]
20. Hiccups, severe vomiting and longitudinally extensive transverse myelitis in a patient with prostatic adenocarcinoma and Aquaporin-4 antibodies. Dinoto A; Bosco A; Sartori A; Bratina A; Bellavita G; Pasquin F; Cheli M; Manganotti P J Neuroimmunol; 2021 Mar; 352():577488. PubMed ID: 33498007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]